Transcript Alison Keating - National Treatment Agency for Substance Misuse

MEDICATIONS IN RECOVERY
APPLICATION IN PRIMARY CARE
10th April 2013
Alison Keating
PHE (London) Head of Drugs and Alcohol
The group’s final report
A lot done.
A lot more to do!
Some people recover fast, some don’t –
all need recovery support.
2
Medication in Recovery – Application in Primary Care
Adaptive treatment
 Plan, review, optimise (measure)
 Phases:
 Engagement and stabilisation
 Preparation for change
 Active change
 Completion
 Layers (of intensity):
 Standard
 Enhanced
 Intensive
3
Medication in Recovery – Application in Primary Care
What works to improve recovery rates?
• Focus and detail, clear planning, local champions and leaders and
aiming high
• Frequent care planning and review – is what we are doing still
bringing benefits?
• Decent length key work sessions
• Psychosocial interventions as well as methadone
• Flexible prescribing
• Considering client strengths
• Recovery conversations
• Offers of detoxification and intensive support for detoxification
4
Medication in Recovery – Application in Primary Care
What works to improve recovery rates?
• Getting abstinent in the first 6 months of treatment
• Mixing with abstinent peers who have been through the system and
succeeded
• Visible treatment exits and role models
• Peer support and mutual aid and aftercare activity
• Employment, Housing support – working at least 1 day a week
• Family support
• An expectation that clinical treatment will end
• Different approach for those who represent to treatment
5
Medication in Recovery – Application in Primary Care
Mutual Aid: A NICE Approved Asset
Issue date: July 2007
Drug misuse
Psychosocial interventions
NICE clinical guideline 51
Developed by the National Collaborating Centre for Mental Health
6
Medication in Recovery – Application in Primary Care
Avoid unintended consequences
Let’s be clear:
 This is about increasing recovery-oriented
ambition and progress for individuals and in
systems where there is not currently enough of
it
 It is not about destabilising - to the point of
unacceptable risk - individuals who are deriving
benefit from OST.
7
Medication in Recovery – Application in Primary Care